FDA Inspection
BioLife Plasma Services LPBioLife Plasma Services LP – FDA Inspection, Sep 18, 2026
Record Details
This FDA Inspection record concerns BioLife Plasma Services LP, with an inspection on September 18, 2026, issued by the Dallas District Office, covering biologics.
View Company Profile
ID · 22e0e91a-f981-404b-b805-7f1673617541
Inspection Facts
- Inspection number
- 1338188
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
- 21 CFR 606.60(a)Provide proper equipment to meet requirements
- 21 CFR 630.15(b)(2)(iii)Donor consent clear
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BioLife Plasma Services LP
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2018 | Not classified | Dallas District Office |
Other documents for BioLife Plasma Services LP
- FDA Inspection 1057709 - 2018-04-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.